INTERVIEW-Top Fidelity stockpicker: Financial markets are 'colossally artificial' BOSTON, May 26- Fidelity's Joel Tillinghast, one of the mutual fund industry's best stockpickers over the past 20 years, said financial markets are "colossally artificial" and cited ride-sharing upstart Uber and negative yielding government bonds as examples. "I think it's colossally artificial, but I don't see it ending," said Tillinghast, who runs the $46...
| By: Tim McLaughlin and Ross Kerber
COLUMN-Top-rated 529 college savings plans probably are not for you LOS ANGELES, May 26- Judging by the latest performance rankings, two 529 college savings plans in particular look enticing. SavingForCollege.com, a plan comparison website that publishes rankings each quarter, said the District of Columbia's direct-sold DC 529 College Savings Program topped the lists for one-, three- and five-year performance as of March 31.
| By: Liz Weston
COLUMN-U.S. courts order 401(k) sponsors to do the right thing CHICAGO, May 21- The U.S. Supreme Court ruled this week that employers have a duty to protect workers in their 401 plans from mutual funds that are too expensive or perform poorly. The high court ruled on a class-action lawsuit against Edison International. St. Louis lawyer Jerome Schlichter, who has made a cause of suing 401 plans to get them to shape up, brought the...
| By: Mark Miller
Cancer conference data may prompt healthcare share volatility Investors were waiting for news that could move share prices from many bigger companies including Bristol-Meyers Squibb Co, Amgen Inc and Celgene Corp. Hot topics at the American Society of Clinical Oncology conference in Chicago will include immuno oncology and CAR-T cell therapies. Shares in Juno Therapeutics Inc, Kite Pharma Inc, BlueBird Bio Inc and...
| By: Sinead Carew